Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers)

Current status

This bill is currently before Parliament.

Policy area

Health, care & disability

What does this bill do?

Lets the Health Department publish clearer information about medical fees and likely out-of-pocket costs for private health care, using Medicare, hospital and insurer billing data already collected by government.

Why was it introduced?

The government introduced the bill because specialist and private health costs were hard for patients to compare before committing to treatment, and voluntary publication on the Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment. had very low take-up. It also sought to close a private health insurance loophole where insurers could close a product and open a similar one at a higher price or with reduced value without the same ministerial premium scrutiny.

Broader context

The bill sits in a wider affordability debate about specialist fees, private health insurance premiums and whether the private system is giving consumers clear value. The original Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment. relied on specialists and insurers opting in, but the explanatory memorandum and minister’s speech said participation remained only about one to two per cent of specialists and 10 per cent of insurers by December 2025. Debate speakers across government, opposition and the crossbench generally accepted that better price information and action on product phoenixingA private health insurance practice where an insurer closes a product and opens a similar one at a higher price or with reduced value, avoiding the ordinary premium-change approval process. were useful, while many argued that transparency alone would not fix access, regional specialist shortages, premium pressure or high gap fees.

Key criticism

The main criticism was not that the transparency and anti-phoenixing measures were wrong, but that they were incomplete. Coalition speakers called for Senate scrutiny and warned of unintended effects on the private health system, while crossbench speakers argued that publishing prices would not itself make specialist care affordable, that the published fee methodology needed safeguards, and that premium approvals needed clear decision timeframes.

Who supported it?

Mark Butler MP introduced this bill. Supportive speeches so far have come from Labor.

Introduced in House 12 Feb 2026
Debate underway in House 25 Mar 2026
Not yet reached Senate
Not yet law

Did it become law?

Not yet

Final passage

No final vote yet

The bill has not yet completed passage through Parliament.

Days since introduction

118 days

Updated 10 June 2026.

Official record

View on APH

Parliament of Australia bill page

What does this bill do?

  1. Lets the Health Department publish clearer information about medical fees and likely out-of-pocket costs for private health care, using Medicare, hospital and insurer billing data already collected by government.

  2. Allows the Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment. to include information about particular medical practitioners, hospitals, insurers, fees, Medicare benefits, gap-cover arrangements and locations, while prohibiting publication of patient personal information.

  3. Creates information-sharing powers so relevant datasets can be linked for publication, and gives medical practitioners, hospitals and insurers an internal review path if they dispute published information.

  4. Requires private health insurers to seek ministerial approval for premiums on new products and for changes that reduce cover, benefits or other terms of an existing product.

  5. Formalises parts of the annual private health insurance premium roundThe annual process through which private health insurers seek approval for premium changes., including public-interest tests, requests for more information, resubmission processes and limited delegation of approval decisions.

Show source excerpts
  1. The amendments will allow for the publication of the relevant data on the Medical Costs Finder, without the need for input from medical practitioners as it will be drawn from Medicare, hospital and insurer billing data collected by government.
    Explanatory memorandum
  2. allow for the publication of information about medical practitioners and their billing (including names, qualifications, specialty, any languages spoken, fees charged by location, their utilisation of gap cover arrangements with insurers)
    Explanatory memorandum
  3. The new Part VE of the HI Act and amended Chapter 6 of the PHI Act will authorise the use and disclosure of the relevant datasets (including linkage between them) supporting Transparency by Default.
    Explanatory memorandum
  4. The new provisions will address product phoenixing. Insurers will no longer be able to open new products or reduce cover/value to consumers of existing products without scrutiny of the proposed premium based on public interest considerations.
    Explanatory memorandum
  5. providing a legislative basis for the Premium Round which has operated administratively for many years, by introducing an ‘approved application period’
    Explanatory memorandum

Broader context for this bill

The bill sits in a wider affordability debate about specialist fees, private health insurance premiums and whether the private system is giving consumers clear value. The original Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment. relied on specialists and insurers opting in, but the explanatory memorandum and minister’s speech said participation remained only about one to two per cent of specialists and 10 per cent of insurers by December 2025. Debate speakers across government, opposition and the crossbench generally accepted that better price information and action on product phoenixingA private health insurance practice where an insurer closes a product and opens a similar one at a higher price or with reduced value, avoiding the ordinary premium-change approval process. were useful, while many argued that transparency alone would not fix access, regional specialist shortages, premium pressure or high gap fees.

  1. 2022

    Voluntary fee publication begins

    Specialists and insurers were able to publish fee and out-of-pocket costThe part of a medical bill the patient pays after Medicare and any private health insurance benefit are applied. information on the Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment., but participation remained voluntary.

    Explanatory memorandum ↗
  2. 2024-25

    Cost keeps patients from specialist care

    The explanatory materials said 8.6 per cent of people, more than 800,000 Australians, delayed or missed specialist care because of cost.

    Explanatory memorandum ↗
  3. Dec 2025

    Medical Costs FinderA government website intended to help patients compare typical medical fees and out-of-pocket costs before choosing treatment. take-up remains low

    Official materials said only one to two per cent of specialists and 10 per cent of insurers were participating on the website.

    Explanatory memorandum ↗
  4. 12 Feb 2026

    Bill introduced in the House

    Mark Butler moved the second reading and described the bill as a transparency and consumer-protection reform for private health consumers.

    Second reading speech ↗
  5. 25 Mar 2026

    House debate continues

    Members debated the bill’s price-transparency and premium-approval measures, with crossbench amendments pressing for affordability reforms, stronger data publication and approval timeframes.

    House debate speeches ↗

How did it move through Parliament?

House Senate
Introduced 12 Feb 2026

The bill was formally presented to the chamber and read a first time, which starts its parliamentary journey.

Introduced and read a first time

Second reading opened 12 Feb 2026

A minister or sponsoring member moved the second reading, opening the main debate on the bill's purpose and principles.

Second reading moved

Community Affairs review 05 Mar 2026

The bill was referred to the Senate Community Affairs Legislation Committee for inquiry, with a report date listed for 15 April 2026.

Referred to committee

APH bill page notes
Second reading debate 25 Mar 2026

Members debated the bill in principle, including its proposed price-transparency rules, premium-approval changes and crossbench amendments.

The main case against this bill

The main criticism was not that the transparency and anti-phoenixing measures were wrong, but that they were incomplete. Coalition speakers called for Senate scrutiny and warned of unintended effects on the private health system, while crossbench speakers argued that publishing prices would not itself make specialist care affordable, that the published fee methodology needed safeguards, and that premium approvals needed clear decision timeframes.

Most criticism was framed as support for the bill’s direction combined with calls for stronger safeguards or broader reform.

Senate scrutiny and unintended consequences

Coalition speakers said they would not block the bill in the House but wanted a Senate inquiry to test data use, specialist and insurer concerns, government overreach and possible effects on innovation and the broader private health system.

Raised by Melissa McIntosh and other Coalition speakers Source ↗

Transparency does not equal affordability

Several crossbench MPs argued that fee publication may show patients the size of the gap but will not cap fees, increase Medicare rebates, expand specialist supply or stop high out-of-pocket costs by itself.

Raised by Monique Ryan and Kate Chaney Source ↗

Need stronger private-system oversight

Sophie Scamps supported the bill but argued the private health system needed an independent authority, stronger payout expectations, fairer contracting and wider reform so the changes would last.

Raised by Sophie Scamps Source ↗

Approval delays

Allegra Spender supported stronger oversight but warned that new ministerial or delegated approval requirements could delay new or improved insurance products unless clear decision timeframes were enforced.

Raised by Allegra Spender Source ↗

Recorded votes

No recorded votes have been found yet for this bill.

Who spoke, and what they said

Start here — lead voices

Sponsor speech Supports

Mark Butler

Australian Labor Party • MP 12 Feb 2026

Mark Butler says the bill gives private health consumers clearer information about practitioner fees and out-of-pocket costs, while closing a product-phoenixing loophole in private health insurance premium oversight.

Read in Hansard ↗
Lead non-major voice Mixed

Allegra Spender

Independent • MP 25 Mar 2026

Allegra Spender supports the bill’s intent but wants enforceable decision timeframes so new ministerial approval requirements do not delay useful insurance products or benefits.

Read in Hansard ↗
Lead voice Mixed

Monique Ryan

Independent • MP 25 Mar 2026

Monique Ryan supports better transparency but says it will not make care affordable by itself, calling for stronger specialist billing reforms, Medicare rebate work, price-updating rules and quality information.

Read in Hansard ↗
Lead voice Mixed

Sophie Scamps

Independent • MP 25 Mar 2026

Sophie Scamps supports the transparency and anti-phoenixing measures, but argues they need to be backed by an independent private health system authority and broader reforms on value, contracting and payouts.

Read in Hansard ↗

All speeches by bloc

Labor

13 speakers · 14 contributions · 13 support

  1. Alice Jordan-Baird Alice Jordan-Baird supports the bill because it would make health costs more accessible to patients and stop insurers using product phoenixingA private health insurance practice where an insurer closes a product and opens a similar one at a higher price or with reduced value, avoiding the ordinary premium-change approval process. to raise prices without oversight.
    “Today I rise to support the Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026, brought forward by the Minister for Health and Ageing”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  2. Joanne Ryan Joanne Ryan supports the bill as a practical response to rising private health costs, saying it helps consumers compare specialist costs and protects them from insurers avoiding premium scrutiny.
    “Like the member opposite who just spoke, I've also met with many constituents about the rising costs of private health care, private health insurance and seeing specialists.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  3. Louise Miller-Frost Louise Miller-Frost supports the bill as a correction to longstanding gaps in private health transparency and premium oversight, while contrasting it with the opposition’s record on Medicare.
    “The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 seeks to course-correct longstanding deficits in the private health system.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  4. Steve Georganas Steve Georganas supports the bill as part of a broader push to make private health costs clearer and to stop insurers avoiding oversight through product changes.
    “I support the introduction and passage of the Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  5. Jo Briskey Jo Briskey supports the bill because it makes fee and out-of-pocket information easier to compare and extends premium scrutiny to new or reduced-value insurance products.
    “This bill takes a clear approach: transparency by default.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  6. Mike Freelander Mike Freelander supports the bill, presenting it as a practical improvement to a health system that needs clearer costs, fairer private health insurance and continued Medicare strengthening.
    “I believe in our health system, and I think that this bill continues with those improvements.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  7. Ali France Ali France supports the bill as a step toward clearer gap-fee information and stronger protection against insurers closing and relaunching similar policies at higher cost or lower value.
    “This bill is a step towards greater transparency of gap fees.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  8. Julie-Ann Campbell 2 contributions Julie-Ann Campbell backs the bill as a consumer-confidence measure, saying patients should be able to compare specialist costs and insurers should not be able to repackage similar products at higher prices without scrutiny.

    Hansard records 2 separate contributions by Julie-Ann Campbell on this bill. They are grouped here so the speaker is listed once.

    Second reading speech Australian Labor Party • MP • 25 Mar 2026

    Julie-Ann Campbell backs the bill as a consumer-confidence measure, saying patients should be able to compare specialist costs and insurers should not be able to repackage similar products at higher prices without scrutiny.

    “This bill helps Australians find the best value when they need specialist medical advice and treatment, and provides more confidence in their private health insurance by outlawing product phoenixing.”
    Read this contribution in Hansard ↗

    Second reading speech Australian Labor Party • MP • 25 Mar 2026

    In a short additional contribution, Julie-Ann Campbell says specialist price information should be as easy to compare as other major household costs.

    “But when you need to see a medical specialist, when the stakes could not be higher, you are expected to make an appointment without knowing what it will cost you, without knowing the impact on your hip pocket and without knowing the price tag for your family.”
    Read this contribution in Hansard ↗
  9. Cassandra Fernando Cassandra Fernando supports the bill as one part of Labor’s health affordability agenda, focused on specialist-fee transparency and stopping insurance practices that avoid scrutiny.
    “I know there is much more work to be done.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  10. Tracey Roberts Tracey Roberts supports the bill as a way to make specialist costs clearer for patients and to stop private health insurers avoiding scrutiny through product phoenixingA private health insurance practice where an insurer closes a product and opens a similar one at a higher price or with reduced value, avoiding the ordinary premium-change approval process..
    “I would like to speak in strong support of the Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  11. Emma McBride Emma McBride supports the bill as a fairness measure that uses existing data to improve price transparency and closes the product-phoenixing loophole in private health insurance.
    “I rise today to speak in support of the Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  12. Emma Comer Emma Comer supports the bill as a consumer-protection reform that makes private health information clearer, protects patients from surprise costs and tightens rules on insurer product changes.
    “At its core, this legislation delivers on the Albanese government's commitment to strengthen Medicare while ensuring Australians who engage with the private health system are better informed, better protected and better supported.”

    Australian Labor Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗

Coalition

4 speakers · 4 mixed

  1. Alison Penfold Alison Penfold supports the bill’s transparency and anti-phoenixing aims, but argues much more is needed on private insurer profits, premium increases and regional health access.
    “Greater transparency in healthcare pricing, which this bill seeks to achieve, is a good thing.”

    National Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  2. Anne Webster Anne Webster supports the bill’s broad aims but criticises Labor over premium increases, regional health access and what she sees as insufficient action on private health affordability.
    “The coalition supports ensuring greater transparency in healthcare pricing and the need to help consumers make informed decisions about their health care and obtain better value from private health insurance.”

    National Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  3. Michael McCormack Michael McCormack says the Coalition will not stand in the way of the bill, while using the debate to stress regional health access problems and the need for services outside metropolitan areas.
    “The coalition is not going to stand in the way of this, because what we want to see is people being able to access help, certainly in regional areas.”

    National Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗
  4. Melissa McIntosh Melissa McIntosh says the Coalition will not block the bill in the House, but argues it needs Senate inquiry scrutiny and will not by itself address rising out-of-pocket costs and premiums.
    “The coalition will not stand in the way of this bill passing the House.”

    Liberal Party • MP • 25 Mar 2026

    Read the full speech in Hansard ↗

Minor parties and independents

4 speakers · 4 mixed

  1. Kate Chaney Kate Chaney supports the bill but says transparency must be paired with safeguards, methodology review, fee monitoring and broader reforms to make specialist care affordable.
    “These are sensible measures, and I'll support them, but they must be seen as the beginning, not the end, of the work that needs to be done.”

    Independent • MP • 25 Mar 2026

    Read the full speech in Hansard ↗

Full record

Full chat